BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28323228)

  • 21. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.
    Paterson DL; Singh N; Gayowski T; Marino IR
    Clin Infect Dis; 1999 Mar; 28(3):683-4. PubMed ID: 10194100
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon.
    Dagher C; Salloum T; Alousi S; Arabaghian H; Araj GF; Tokajian S
    PLoS One; 2018; 13(9):e0203323. PubMed ID: 30188911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amoxicillin/clavulanate (Augmentin) resistant Escherichia coli in bacterial peritonitis after abdominal surgery--clinical outcome in ICU patients.
    Rahnama'i MS; Wagenvoort JH; van der Linden CJ
    Neth J Med; 2009 May; 67(5):173-6. PubMed ID: 19581666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new isoquinoline alkaloid with anti-microbial properties from Berberis jaeschkeana Schneid. var. jaeschkeana.
    Alamzeb M; Khan MR; Mamoon-Ur-Rashid ; Ali S; Khan AA
    Nat Prod Res; 2015; 29(8):692-7. PubMed ID: 25424893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli: development of carbapenem resistance during therapy.
    Hong T; Moland ES; Abdalhamid B; Hanson ND; Wang J; Sloan C; Fabian D; Farajallah A; Levine J; Thomson KS
    Clin Infect Dis; 2005 May; 40(10):e84-6. PubMed ID: 15844056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits.
    Gupta SK; Agarwal R; Srivastava S; Agarwal P; Agrawal SS; Saxena R; Galpalli N
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4036-40. PubMed ID: 18421073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice: a preliminary study.
    Pai KS; Srilatha P; Suryakant K; Setty MM; Nayak PG; Rao CM; Baliga MS
    Pharm Biol; 2012 Mar; 50(3):270-7. PubMed ID: 22085276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps.
    Mitgang EA; Hartley DM; Malchione MD; Koch M; Goodman JL
    Int J Antimicrob Agents; 2018 Sep; 52(3):372-384. PubMed ID: 29864500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of animal experimental model for bacterial peritonitis].
    Montenegro O; Illescas S; González JC; Padilla D; Villarejo P; Baladrón V; Galán R; Bejarano N; Medina-Prado L; Villaseca N; Pérez-Ortiz JM; Muñoz-Rodríguez JR; Santiago JL; Redondo FJ
    Rev Esp Quimioter; 2020 Feb; 33(1):18-23. PubMed ID: 31795629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model.
    Knappe D; Fritsche S; Alber G; Köhler G; Hoffmann R; Müller U
    J Antimicrob Chemother; 2012 Oct; 67(10):2445-51. PubMed ID: 22729924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberis aristata Ameliorates Adjuvant-Induced Arthritis by Inhibition of NF-κB and Activating Nuclear Factor-E2-related Factor 2/hem Oxygenase (HO)-1 Signaling Pathway.
    Kumar R; Nair V; Gupta YK; Singh S; Arunraja S
    Immunol Invest; 2016 Aug; 45(6):473-89. PubMed ID: 27294302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic Characterization of Multidrug-resistant Escherichia Coli with Special Reference to Extended-spectrum-beta-lactamases and Metallo-beta-lactamases in a Tertiary Care Center.
    Shrestha B; Shrestha S; Mishra SK; Kattel HP; Tada T; Ohara H; Kirikae T; Rijal BP; Sherchand JB; Pokhrel BM
    JNMA J Nepal Med Assoc; 2015; 53(198):89-95. PubMed ID: 26994027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
    Thakur P; Chawla R; Chakotiya AS; Tanwar A; Goel R; Narula A; Arora R; Sharma RK
    Phytother Res; 2016 Feb; 30(2):314-22. PubMed ID: 26620305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats.
    Singh J; Kakkar P
    J Ethnopharmacol; 2009 May; 123(1):22-6. PubMed ID: 19429334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli.
    Tsumura H; Hiyama E; Kodama T; Sueda T; Yokoyama T
    Int J Antimicrob Agents; 2003 May; 21(5):463-70. PubMed ID: 12727081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial molecular epidemiology of carbapenem-resistant and New Delhi metallo beta-lactamase (blaNDM)-producing Escherichia coli in the piglets of organized farms in India.
    Pruthvishree BS; Vinodh Kumar OR; Sinha DK; Malik YPS; Dubal ZB; Desingu PA; Shivakumar M; Krishnaswamy N; Singh BR
    J Appl Microbiol; 2017 Jun; 122(6):1537-1546. PubMed ID: 28345184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.
    Ng SMS; Sioson JSP; Yap JM; Ng FM; Ching HSV; Teo JWP; Jureen R; Hill J; Chia CSB
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):141-148. PubMed ID: 29019016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.